Business Description
Ironwood Pharmaceuticals is a Boston-based company founded in 1998 that develops and sells treatments for digestive and rare medical conditions across the United States and global markets. Its primary product, sold under the brand names LINZESS and CONSTELLA, helps adults and children manage conditions such as irritable bowel syndrome and chronic constipation. The company is also working on new treatments targeting painful conditions like endometriosis and short bowel syndrome, with support from major partners including AbbVie, AstraZeneca, and Astellas Pharma.
